Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML

• DOI: 10.1182/bloodadvances.2022008991
• Publication Date: 2022-12-30T15:06:16Z
• Authors: Toshiki Terao; Ken-ichi Matsuoka; Hiroko Ueda; Akifumi Matsumura; Chisato Matsubara; Kaho Kondo; Takumi Kondo; Hideaki Fujiwara; Noboru Asada; Daisuke Ennishi; Hisakazu Nishimori; Keiko Fujii; Nobuharu Fujii; Yoshinobu Maeda
• Keywords: Leukemia, Myeloid, Acute; 03 medical and health sciences; Aniline Compounds; 0302 clinical medicine; Pyrazines; Research Letter; Humans; Neoplasm Recurrence, Local